Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

The utility of a genetic kidney disease clinic employing a broad range of genomic testing platforms: experience of the Irish Kidney Gene Project

EAE. Elhassan, SL. Murray, DM. Connaughton, C. Kennedy, S. Cormican, C. Cowhig, C. Stapleton, MA. Little, K. Kidd, AJ. Bleyer, M. Živná, S. Kmoch, NK. Fennelly, B. Doyle, A. Dorman, MD. Griffin, L. Casserly, PC. Harris, F. Hildebrandt, GL....

. 2022 ; 35 (6) : 1655-1665. [pub] 20220131

Jazyk angličtina Země Itálie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc22025334

BACKGROUND AND AIMS: Genetic testing presents a unique opportunity for diagnosis and management of genetic kidney diseases (GKD). Here, we describe the clinical utility and valuable impact of a specialized GKD clinic, which uses a variety of genomic sequencing strategies. METHODS: In this prospective cohort study, we undertook genetic testing in adults with suspected GKD according to prespecified criteria. Over 7 years, patients were referred from tertiary centres across Ireland to an academic medical centre as part of the Irish Kidney Gene Project. RESULTS: Among 677 patients, the mean age was of 37.2 ± 13 years, and 73.9% of the patients had family history of chronic kidney disease (CKD). We achieved a molecular diagnostic rate of 50.9%. Four genes accounted for more than 70% of identified pathogenic variants: PKD1 and PKD2 (n = 186, 53.4%), MUC1 (8.9%), and COL4A5 (8.3%). In 162 patients with a genetic diagnosis, excluding PKD1/PKD2, the a priori diagnosis was confirmed in 58% and in 13% the diagnosis was reclassified. A genetic diagnosis was established in 22 (29.7%) patients with CKD of uncertain aetiology. Based on genetic testing, a diagnostic kidney biopsy was unnecessary in 13 (8%) patients. Presence of family history of CKD and the underlying a priori diagnosis were independent predictors (P < 0.001) of a positive genetic diagnosis. CONCLUSIONS: A dedicated GKD clinic is a valuable resource, and its implementation of various genomic strategies has resulted in a direct, demonstrable clinical and therapeutic benefits to affected patients.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22025334
003      
CZ-PrNML
005      
20221031100406.0
007      
ta
008      
221017s2022 it f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s40620-021-01236-2 $2 doi
035    __
$a (PubMed)35099770
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a it
100    1_
$a Elhassan, Elhussein A E $u Department of Nephrology and Transplantation, Beaumont Hospital, Dublin, Ireland. elhusseinelhassan@beaumont.ie $u Department of Medicine, Dublin, Royal College of Surgeons in Ireland, Dublin, Ireland. elhusseinelhassan@beaumont.ie $1 https://orcid.org/0000000286898602
245    14
$a The utility of a genetic kidney disease clinic employing a broad range of genomic testing platforms: experience of the Irish Kidney Gene Project / $c EAE. Elhassan, SL. Murray, DM. Connaughton, C. Kennedy, S. Cormican, C. Cowhig, C. Stapleton, MA. Little, K. Kidd, AJ. Bleyer, M. Živná, S. Kmoch, NK. Fennelly, B. Doyle, A. Dorman, MD. Griffin, L. Casserly, PC. Harris, F. Hildebrandt, GL. Cavalleri, KA. Benson, PJ. Conlon
520    9_
$a BACKGROUND AND AIMS: Genetic testing presents a unique opportunity for diagnosis and management of genetic kidney diseases (GKD). Here, we describe the clinical utility and valuable impact of a specialized GKD clinic, which uses a variety of genomic sequencing strategies. METHODS: In this prospective cohort study, we undertook genetic testing in adults with suspected GKD according to prespecified criteria. Over 7 years, patients were referred from tertiary centres across Ireland to an academic medical centre as part of the Irish Kidney Gene Project. RESULTS: Among 677 patients, the mean age was of 37.2 ± 13 years, and 73.9% of the patients had family history of chronic kidney disease (CKD). We achieved a molecular diagnostic rate of 50.9%. Four genes accounted for more than 70% of identified pathogenic variants: PKD1 and PKD2 (n = 186, 53.4%), MUC1 (8.9%), and COL4A5 (8.3%). In 162 patients with a genetic diagnosis, excluding PKD1/PKD2, the a priori diagnosis was confirmed in 58% and in 13% the diagnosis was reclassified. A genetic diagnosis was established in 22 (29.7%) patients with CKD of uncertain aetiology. Based on genetic testing, a diagnostic kidney biopsy was unnecessary in 13 (8%) patients. Presence of family history of CKD and the underlying a priori diagnosis were independent predictors (P < 0.001) of a positive genetic diagnosis. CONCLUSIONS: A dedicated GKD clinic is a valuable resource, and its implementation of various genomic strategies has resulted in a direct, demonstrable clinical and therapeutic benefits to affected patients.
650    _2
$a dospělí $7 D000328
650    _2
$a genetické testování $x metody $7 D005820
650    _2
$a lidé $7 D006801
650    _2
$a ledviny $7 D007668
650    _2
$a lidé středního věku $7 D008875
650    _2
$a mutace $7 D009154
650    12
$a polycystické ledviny autozomálně dominantní $x diagnóza $7 D016891
650    _2
$a prospektivní studie $7 D011446
650    12
$a chronická renální insuficience $x diagnóza $x epidemiologie $x genetika $7 D051436
650    _2
$a kationtové kanály TRPP $x genetika $7 D050396
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Murray, Susan L $u Department of Nephrology and Transplantation, Beaumont Hospital, Dublin, Ireland $u Department of Medicine, Dublin, Royal College of Surgeons in Ireland, Dublin, Ireland
700    1_
$a Connaughton, Dervla M $u Schulich School of Medicine and Dentistry, University of Western Ontario, London, ON, Canada $u Division of Nephrology, Department of Medicine, London Health Sciences Centre, London, ON, Canada
700    1_
$a Kennedy, Claire $u Department of Nephrology and Transplantation, Beaumont Hospital, Dublin, Ireland
700    1_
$a Cormican, Sarah $u Department of Nephrology and Transplantation, Beaumont Hospital, Dublin, Ireland
700    1_
$a Cowhig, Cliona $u Department of Nephrology and Transplantation, Beaumont Hospital, Dublin, Ireland
700    1_
$a Stapleton, Caragh $u School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons, Dublin, Ireland
700    1_
$a Little, Mark A $u Trinity Health Kidney Centre, Trinity Translational Medicine Institute, Trinity College Dublin, St James' Street, Dublin 8, Ireland
700    1_
$a Kidd, Kendrah $u Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, NC, USA
700    1_
$a Bleyer, Anthony J $u Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, NC, USA
700    1_
$a Živná, Martina $u Research Unit for Rare Diseases, Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
700    1_
$a Kmoch, Stanislav $u Section on Nephrology, Wake Forest School of Medicine, Winston-Salem, NC, USA $u Research Unit for Rare Diseases, Department of Paediatrics and Inherited Metabolic Disorders, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic
700    1_
$a Fennelly, Neil K $u Department of Pathology, Beaumont Hospital, Dublin, Ireland
700    1_
$a Doyle, Brendan $u Department of Pathology, Beaumont Hospital, Dublin, Ireland
700    1_
$a Dorman, Anthony $u Department of Pathology, Beaumont Hospital, Dublin, Ireland $u Department of Pathology, Royal College of Surgeons in Ireland, Dublin, Ireland
700    1_
$a Griffin, Matthew D $u Nephrology Department, Galway University Hospitals, Saolta University Healthcare Group, Galway, Ireland $u Regenerative Medicine Institute (REMEDI) at CÚRAM Centre for Research in Medical Devices, School of Medicine, National University of Ireland, Galway, Ireland
700    1_
$a Casserly, Liam $u Department of Nephrology and Internal Medicine, University Hospital Limerick, Limerick, Ireland
700    1_
$a Harris, Peter C $u Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA
700    1_
$a Hildebrandt, Friedhelm $u Department of Paediatrics, Boston Children's Hospital, Harvard Medical School, Boston, MA, 02115, USA
700    1_
$a Cavalleri, Gianpiero L $u School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons, Dublin, Ireland
700    1_
$a Benson, Katherine A $u School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons, Dublin, Ireland
700    1_
$a Conlon, Peter J $u Department of Nephrology and Transplantation, Beaumont Hospital, Dublin, Ireland $u Department of Medicine, Dublin, Royal College of Surgeons in Ireland, Dublin, Ireland
773    0_
$w MED00002821 $t JN. Journal of nephrology $x 1724-6059 $g Roč. 35, č. 6 (2022), s. 1655-1665
856    41
$u https://pubmed.ncbi.nlm.nih.gov/35099770 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20221017 $b ABA008
991    __
$a 20221031100404 $b ABA008
999    __
$a ok $b bmc $g 1854844 $s 1176624
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 35 $c 6 $d 1655-1665 $e 20220131 $i 1724-6059 $m JN. Journal of nephrology $n JN, J. Nephrol. (Milano, 1992) $x MED00002821
LZP    __
$a Pubmed-20221017

Najít záznam

Citační ukazatele

Možnosti archivace